Serum interleukin-6 in primary fibromyalgia syndrome patients: Impact on disease burden, severity, quality of life and sleep

Aim of the work: To assess serum interleukin-6 (IL-6) level in primary fibromyalgia syndrome (FMS) patients and to study its relation to disease burden parameters Patients and methods: Forty primary FMS patients and 40 age and sex matched controls were studied. Patients answered multiple questionnai...

Full description

Bibliographic Details
Main Authors: Riham Ahmed, Nema Soliman, Rehab Abo El Gheit, Shereen Elwan
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Egyptian Rheumatologist
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110116421000715